S. Ikeda

Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor

T. Minegishi, Soichi Yamashita, Kazuto Nakamura, 2015, BMC Cancer.

Glucose-Regulated Protein, 78-Kilodalton Is a Modulator of Luteinizing Hormone Receptor Expression in Luteinizing Granulosa Cells in Rats1

T. Minegishi, Kazuto Nakamura, Yoshikazu Kitahara, 2013, Biology of reproduction.

Title: Glucose-Regulated Protein, 78-kilodalton as a Modulator of Luteinizing Hormone Receptor Expression in Luteinizing Granulosa Cells in Rats 1 Short title: The regulation of LH receptor expression by GRP78

T. Minegishi, Kazuto Nakamura, Yoshikazu Kitahara, 2012 .

Effect of estrogen on the expression of luteinizing hormone-human chorionic gonadotropin receptor messenger ribonucleic acid in cultured rat granulosa cells.

K. Miyamoto, T. Minegishi, Soichi Yamashita, 2008, Endocrinology.

Expression of LH-alpha and -beta subunit mRNAs in the rat placenta.

H. Uchida, K. Shiota, T. Ogawa, 1997, Endocrine journal.

Regulation of human luteinizing hormone receptor in the ovary

T. Minegishi, Soichi Yamashita, Kazuto Nakamura, 2008, Reproductive medicine and biology.

GRP78 induced by estrogen plays a role in the chemosensitivity of endometrial cancer.

T. Minegishi, H. Aoki, Kazuto Nakamura, 2012, Gynecologic oncology.

High Expression of Ubiquitin C-terminal Hydrolase L1 Is Associated With Poor Prognosis in Endometrial Cancer Patients

Takashi Minegishi, Hiroshi Kishi, T. Minegishi, 2018, International Journal of Gynecologic Cancer.

Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor

T. Minegishi, Soichi Yamashita, Kazuto Nakamura, 2015, BMC Cancer.